[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[2]WATERS JK,REZNIK SI.Update on management of squamous cell esophageal cancer[J].Curr Oncol Rep,2022,24(3):375-385.
[3]FENG Q,ZHANG H,YAO D,et al.Emerging role of non-coding RNAs in esophageal squamous cell carcinoma [J].Int J Mol Sci,2019,21(1):258.
[4]FANG X,SHRESTHA SM,REN LH,et al.Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma [J].FEBS Open Bio,2021,11(11):2870-2887.
[5]SHEN Y,SHAO Y,NIU C,et al.Systematic identification of circRNA-miRNA-mRNA regulatory network in esophageal squamous cell carcinoma [J].Front Genet,2021,12:580390.
[6]REINFELD BI,MADDEN MZ,WOLF MM,et al.Cell-programmed nutrient partitioning in the tumour microenvironment [J].Nature,2021,593(7858):282-288.
[7]LIANG Z,ZHAO B,HOU J,et al.CircRNA circ-OGDH (hsa_circ_0003340) acts as a ceRNA to regulate glutamine metabolism and esophageal squamous cell carcinoma progression by the miR-615-5p/PDX1 axis [J].Cancer Manag Res,2021,13:3041-3053.
[8]ZHOU X,LIU K,CUI J,et al.Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer [J].J Exp Clin Cancer Res,2021,40(1):124.
[9]TAO M,ZHENG M,XU Y,et al.CircRNAs and their regulatory roles in cancers [J].Mol Med,2021,27(1):94.
[10]HARPER KL,MOTTRAM TJ,WHITEHOUSE A.Insights into the evolving roles of circular RNAs in cancer [J].Cancers (Basel),2021,13(16):4180.
[11]LI J,SUN D,PU W,et al.Circular RNAs in cancer:Biogenesis,function,and clinical significance [J].Trends Cancer,2020,6(4):319-336.
[12]LI T,SHAO Y,FU L,et al.Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection [J].J Mol Med (Berl),2018,96(1):85-96.
[13]MASISI BK,EL ANSARI R,ALFARSI L,et al.The role of glutaminase in cancer [J].Histopathology,2020,76(4):498-508.
[14]YANG WH,QIU Y,STAMATATOS O,et al.Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy [J].Trends Cancer,2021,7(8):790-804.
[15]CHU J,NIU X,CHANG J,et al.Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma [J].Theranostics,2020,10(8):3488-3502.
[16]SUN N,LIANG Y,CHEN Y,et al.Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis [J].Int J Mol Med,2019,44(6):2189-2200.
[17]CEN L,LIU R,LIU W,et al.Competing endogenous RNA networks in glioma [J].Front Genet,2021,12:675498.
[18]BAI Q,PAN Z,NABI G,et al.Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer [J].Am J Cancer Res,2022,12(3):961-973.
[19]CAO J,ZHANG X,XU P,et al.Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway [J].J Exp Clin Cancer Res,2021,40(1):6.
[20]LI K,CAO J,ZHANG Z,et al.Circular RNA circGSK3B promotes cell proliferation,migration,and invasion by sponging miR-1265 and regulating CAB39 expression in hepatocellular carcinoma [J].Front Oncol,2020,10:598256.